Prenatal
Natural health product licensed in Canada
- Other names
- Perfect Prenatal, Prenatal Boost, Prenatal Multi, Prenatal complete, Purely Prenatal, the Complete Prenatal multi
- Licence holder
- Luvolux Inc.
- NPN or DIN-HM
- 80088790
- Status
- Active licence
- Licence date
- 18 October 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 20 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 16.6 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine E: up to 52 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Fer: up to 30 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B12 Source : Méthylcobalamine | 50 mcg | 100 µg |
| Vitamine K1 Source : Vitamine K1 | 33.3 mcg | 66.6 µg |
| Potassium Source : Citrate de potassium | 12.5 mg | 25,000 µg |
| Zinc Source : Citrate de zinc | 10 mg | 20,000 µg |
| Vitamine D Source : Cholécalciférol | 8.3 mcg | 16.6 µg |
| Vitamine E Source : d-alpha tocophérol | 18.3 UI | Not calculated |
| Riboflavine Source : Riboflavine 5'-phosphate | 1.6 mg | 3,200 µg |
| Molybdène Source : Molybdène | 25 mcg | 50 µg |
| Vitamine E Source : d-alpha tocophérol | 26 mg | 52,000 µg |
| Bore Source : Citrate de bore | 250 mcg | Not calculated |
| Cuivre Source : Citrate de cuivre (II) | 500 mcg | 1,000 µg |
| Fer Source : Citrate de fer (II) | 15 mg | 30,000 µg |
| Thiamine Source : Chlorhydrate de thiamine | 1.6 mg | 3,200 µg |
| Iode Source : Iodure de potassium | 75 mcg | 150 µg |
| Ubiquinol Source : Ubiquinol | 100 mg | Not calculated |
| Biotine Source : Biotine | 50 mcg | 100 µg |
| Magnésium Source : Glycinate de magnésium | 25 mg | 50,000 µg |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Helps to form red blood cells. Helps to support normal early fetal development. Helps to support normal early development of the fetal brain and spinal cord. Helps to reduce the risk of neural tube defects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Helps to maintain the body's ability to metabolize nutrients. Helps normal growth. Helps in energy production. Helps in the process of normal cell division.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you experience gastrointestinal symptoms such as nausea, vomiting, abdominal pain, dyspepsia, heartburn or diarrhoea, discontinue use and consult a health care practitioner. If you have asthma or peptic ulcer disease, consult a health care practitioner prior to use. If you are taking anticoagulants or products containing acetylsalicylic acid (ASA) or other salicylates, consult a health care practitioner prior to use. If you have a history of non-melanoma skin cancer, consult a health care practitioner prior to use. If you have a liver disorder, consult a health care practitioner prior to use. If you are taking blood thiners consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80088790
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.